DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/msjp88/recent_advances_in) has announced the addition of Elsevier Science and Technology's new report "Recent Advances in Cancer Research and Therapy" to their offering.

Cancer continues to be one of the major causes of death throughout the developed world, which has led to increased research on effective treatments. Because of this, in the past decade, rapid progress in the field of cancer treatment has been seen. Recent Advances in Cancer Research and Therapy reviews in specific details some of the most effective and promising treatments developed in research centers worldwide. While referencing advances in traditional therapies and treatments such as chemotherapy, this book also highlights advances in biotherapy including research using Interferon and Super Interferon, HecI based and liposome based therapy, gene therapy, and p53 based cancer therapy. There is also a discussion of current cancer research in China including traditional Chinese medicine. Written by leading scientists in the field, this book provides an essential insight into the current state of cancer therapy and treatment.

Key Topics Covered:

1. Biotherapy of Cancer: Progress in China

2. Cancer Targeting Gene-Viro-Therapy (CTGVT) and Its Promising Future

3. Relationship Between Antiproliferative Activities and Class I MHC Surface Expression of Mouse Interferon Proteins on B16-F10 Melanoma Cells

4. Mitotic Regulator Hec1 as a Potential Target for Developing Breast Cancer Therapeutics

5. Advances in Liposome-based Targeted Gene Therapy of Cancer

6. Re-wiring the Intracellular Signaling Network in Cancer

Read the original here:
Research and Markets: Recent Advances in Cancer Research and Therapy - Increased Research on one of the Major Causes ...

Comments are closed.